» Go to news main
Molly Appeal paves the way to precision cancer treatment
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
- Medical education in the time of COVID‑19: Dal Med takes doctor training online; clerks step up to volunteer
- Dalhousie Neurosurgery Resident Receives Top Prize for Clinical Neuroscience Research
- Facing the new coronavirus: Dalhousie researchers help galvanize scientific response to the new pandemic
- EUPHORIA! 2020
- Chair Chats: connecting through shared experiences
- Feds fund innovative health research happening at Dal, NSHA and IWK
- Cracking the code on opioid‑prescribing patterns in Nova Scotia
- Dalhousie Medicine New Brunswick launches first‑of‑its‑kind medical education podcast: The Fac Dev Lounge